Combating Illicit Xylazine Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 12, 2025)
Combating Illicit Xylazine Act
This bill regulates xylazine under the Controlled Substances Act (CSA).
Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.
This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.
Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.
The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.
The bill also exempts xylazine manufacturers from the CSA's physical security requirements.
Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.
What just happenedSep 16, 2026
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
Who’s behind it
- Engrossed in HouseSep 15, 2026
- Reported in HouseSep 14, 2026
- Introduced in HouseFeb 12, 2025
- Sep 16, 2026Calendars
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
- Sep 15, 2026FloorH38310
Motion to reconsider laid on the table Agreed to without objection.
- Sep 15, 2026FloorH37300
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
- Sep 15, 2026Floor8000
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- Sep 15, 2026FloorH8D000
DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
- Sep 15, 2026FloorH30000
Considered under suspension of the rules. (consideration: CR H5671-5673)
- Sep 15, 2026FloorH30300
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- Sep 14, 2026CalendarsH12410
Placed on the Union Calendar, Calendar No. 715.
- Sep 14, 2026DischargeH12300
Committee on the Judiciary discharged.
Judiciary Committee - Sep 14, 2026Committee5500
Committee on the Judiciary discharged.
Judiciary Committee - Sep 14, 2026CommitteeH12200
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
Energy and Commerce Committee - Sep 14, 2026Committee5000
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
Energy and Commerce Committee - Jul 21, 2026Committee
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
Energy and Commerce Committee - Jul 21, 2026Committee
Committee Consideration and Mark-up Session Held
Energy and Commerce Committee - Jul 20, 2026Committee
Committee Consideration and Mark-up Session Held
Energy and Commerce Committee - Jun 25, 2026Committee
Forwarded by Subcommittee to Full Committee by Voice Vote.
Health Subcommittee - Jun 25, 2026Committee
Subcommittee Consideration and Mark-up Session Held
Health Subcommittee - Feb 12, 2025Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 12, 2025IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Feb 12, 2025IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Feb 12, 2025IntroReferralIntro-H
Introduced in House
- Feb 12, 2025IntroReferral1000
Introduced in House